Pentagastrin has panic-inducing properties in obsessive compulsive disorder (Q42552995)

2 November 2017

title

Pentagastrin has panic-inducing properties in obsessive compulsive disorder (English)

1 reference

obsessive-compulsive disorder

2 November 2017

main subject

1 reference

A S de Leeuw

1

1 reference

2 November 2017

J A Den Boer

series ordinal

2

1 reference

2 November 2017

B R Slaap

series ordinal

3

1 reference

2 November 2017

H G Westenberg

series ordinal

4

1 reference

2 November 2017

publication date

1 August 1996

1 reference

2 November 2017

number of pages

6

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

2 November 2017

volume

126

1 reference

2 November 2017

issue

4

1 reference

2 November 2017

page(s)

339-344

1 reference

Cholecystokinin-4 and panic

2 November 2017

cites work

1 reference

Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder.

21 January 2018

1 reference

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

21 January 2018

1 reference

Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder

21 January 2018

1 reference

Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects

21 January 2018

1 reference

Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings

21 January 2018

1 reference

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

21 January 2018

1 reference

Lactate infusions in obsessive-compulsive disorder

21 January 2018

1 reference

Serotonergic Function in Obsessive-Compulsive Disorder

21 January 2018

1 reference

Anxiety sensitivity and response to cholecystokinin tetrapeptide in healthy volunteers

21 January 2018

1 reference

5-Hydroxytryptamine1A receptor responsivity in obsessive-compulsive disorder. Comparison of patients and controls

21 January 2018

1 reference

Lactate provocation of panic attacks. II. Biochemical and physiological findings

21 January 2018

1 reference

Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls

21 January 2018

1 reference

m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: Absence of symptom exacerbation

21 January 2018

1 reference

12 December 2020

A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP.

1 reference

12 December 2020

Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses

1 reference

12 December 2020

Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder

1 reference

12 December 2020

Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers

1 reference

12 December 2020

Lactate infusions: the role of baseline anxiety

1 reference

12 December 2020

Noradrenergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses to clonidine and comparison to healthy controls

1 reference

12 December 2020

Pentagastrin infusions in patients with panic disorder II. Neuroendocrinology

1 reference

12 December 2020

Neuroendocrine and behavioral responses to challenge with the indirect serotonin agonist dl-fenfluramine in adults with obsessive-compulsive disorder

1 reference

12 December 2020

CCK-33 antagonizes apomorphine-induced growth hormone secretion and increases basal prolactin levels in man

1 reference

12 December 2020

Alpha 2-adrenoreceptor status in obsessive-compulsive disorder

1 reference

12 December 2020

Behavioral biochemical and neuroendocrine concomitants of lactate-induced panic anxiety

1 reference

12 December 2020

The determination of cortisol in human plasma: evaluation and comparison of seven assays

1 reference

12 December 2020

Effects of yohimbine in obsessive compulsive disorder

1 reference

12 December 2020

Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02247385

1 reference

Dimensions Publication ID

2 November 2017

1009203417

0 references

1 reference